053 2-Chlorodeoxyadenosine as initial therapy in chronic lymphocytic leukaemia

MLA

J Matthews, et al. “053 2-Chlorodeoxyadenosine as Initial Therapy in Chronic Lymphocytic Leukaemia.” Hematology and Cell Therapy, vol. 39, Nov. 1997, pp. S83–102. EBSCOhost, https://doi.org/10.1007/s00282-997-0083-7.

APA

J Matthews, B Dale, I Bunce, SP Mulligan, John Bashford, D Gill, & P Eliadis. (1997). 053 2-Chlorodeoxyadenosine as initial therapy in chronic lymphocytic leukaemia. Hematology and Cell Therapy, 39, S83–S102. https://doi.org/10.1007/s00282-997-0083-7

Chicago

J Matthews, B Dale, I Bunce, SP Mulligan, John Bashford, D Gill, and P Eliadis. 1997. “053 2-Chlorodeoxyadenosine as Initial Therapy in Chronic Lymphocytic Leukaemia.” Hematology and Cell Therapy 39 (November): S83–102. doi:10.1007/s00282-997-0083-7.